Synthesis of arylidenehydrazono- and glycopyranosylhydrazino- sulfonylbenzylidene-2,4-imidazolidinediones as potential antiviral and antitumoral agents

Carbohydrate Research

Volumn 306, Issue 4, 1998, Pages 567-573

  Khodair, Ahmed I ^a,b  

^a UNIVERSITÉ DE POITIERS   (France)

^b TANTA UNIVERSITY   (Egypt)

Author keywords

2,4 Imidazolidinediones; Antitumor agents; Antiviral; Glycopyranosylhydrazines; Hydrazones

Indexed keywords

5 [4 (2 ARYLIDENE)HYDRAZONOSULFONYLBENZYLIDINE] 2,4 IMIDAZOLIDINEDIONE; 5 [4 (2 BETA DEXTRO GLYCOPYRANOSYL)HYDRAZINOSULFONYLBENZYLIDINE] 2,4 IMIDAZOLIDINE; ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; DRUG CONFORMATION; DRUG SYNTHESIS; NOTE; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

ANTINEOPLASTIC AGENTS; ANTIVIRAL AGENTS; BENZYLIDENE COMPOUNDS; GLYCOSIDES; HYDRAZINES; IMIDAZOLES;

EID: 0031820825     PISSN: 00086215     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6215(98)00024-X     Document Type: Note

References (25)

1. [1] N. Mehta, C.A. Risinger and F.E. Soroko, J. Med. Chem., 24 (1981) 465-468.
2. [2] F.L. Wessels, T.J. Schwan and S.F. Pong, J. Pharm. Sci., 69 (1980) 1102-1104.
3. [3] K.R. Bharucha, V. Pavilinis, D. Ajdukovic and H.M. Shrenk, Ger. Offen., 2 329 745 (1974); Chem. Abstr., 80 (1974) 95948d.
4. [3] K.R. Bharucha, V. Pavilinis, D. Ajdukovic and H.M. Shrenk, Ger. Offen., 2 329 745 (1974); Chem. Abstr., 80 (1974) 95948d.
5. [4] A.G. Caldwell, C.J. Harris, R. Stepney and N. Wittaker, J. Chem. Soc., Perkin Trans., 1 (1980) 495-505.
6. [5] R.J. Cremlyn, R.S. Elias, M.J.A. Geoghegan and J.T. Braunholtz, Br. Patent 967, 166 (1964) Chem. Abstr., 62 (1965) 7768g.
7. [6] R.J. Cremlyn, F.J. Swinbourne, O.O. Shode and J. Lynch, J. Heterocycl. Chem., 24 (1987) 117-121.
8. [7] R.J. Cremlyn, F.J. Swinbourne and L. Goodman, Phosphorus and Sulfur, 28 (1986) 395-398.
9. [8] R.J. Cremlyn, S. Jethwa, G. Joiner and D. White, Phosphorus and Sulfur, 36 (1988) 99-109.
10. [9] K. Inagaki, I. Miwa, T. Yashiro and J. Okuda, Chem. Pharm. Bull., 30 (1982) 3244-3254.
11. [10] M.S. Malamas, K. Sestanj and J. Mikken, Eur.J. Med. Chem., 26 (1991) 369-374.
12. [11] A.I. Khodair, H.I. EL-Subagh and A.A. El-Emam, Bull. Chim. Farm., 136 (1997) 561-567.
13. [12] A.M. Al-Obaid, H.I. EL-Subagh, A.I. Khodair and M.M. A. Elmazar, Anti-Cancer Drugs, 7 (1996) 873-880.
14. [13] A.A. El-Barbary, A.I. Khodair, E.B. Pedersen and C. Nielsen, J. Med. Chem., 37 (1994) 73-77.
15. [14] A.A. El-Barbary, A.I. Khodair and E.B. Pedersen, J. Org Chem., 58 (1993) 5994-5999.
16. [15] A.A. El-Barbary, A.I. Khodair and E.B. Pedersen, Arch. Pharm. (Weinheim), 327 (1994) 653-655.
17. [16] A.I. Khodair and E.E. Ibrahim, Nucleosides & Nucleotides, 15 (1996) 1927-1943.
18. [17] S.F. Tan, K.P. Ang and Y.F. Fong, J. Chem. Soc..Perkin Trans., 2 (1986) 1941-1944.
19. [18] G. Lock and K. Stach, Ber. Dtsch Chem. Ges., 76 (1943) 1252-1256.
20. [19] A.I. Khodair and P. Bertrand, unpublished results.
21. [20] H.H. Stroh, A. Arnold and H.G. Scharnow, Ber., 98 (1965) 1404-1410.
22. [21] C. Chavis, C. De Gourcy and J.L. Imbach, Carbohydr. Res., 135 (1984) 13-27.
23. [22] O.W. Weislow, R. Kiser, D. Fine, J. Bader, R.H. Skoemaker and M.R. Boyd, J. Natl. Concer Inst., 81 (1989), 577-586.
24. [23] A. Monks, D. Scudiero, P. Skehan, R. Shoemaker, K. Poull, D. Vistica, C. Hose, J. Langly, P. Cronise, A. Viagro-Wolff, M. Gray-Goodrish, H. Compell and M. Boyd, J. Natl. Cancer Inst., 83 (1991) 757-766.
25. [24] M.R. Boyd and K.D. Poull, Drug Dev. Res., 34 (1995) 91-109.